계명대학교 의학도서관 Repository

Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma®) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+ metastatic breast cancer (KCSG BR 18-14/KM10B)

Metadata Downloads
Author(s)
Sung Hoon SimJeong Eun KimMin Hwan KimYeon Hee ParkJee Hyun KimKoung Jin SuhSu-Jin KohKyong Hwa ParkMyoung Joo KangMi Sun AhnKyoung Eun LeeHee-Jun KimHee Kyung AhnHan Jo KimKeon Uk ParkJae Ho ByunJin Hyun ParkGyeong-Won LeeKeun Seok LeeJoohyuk SohnKyung Hae JungIn Hae Park
Keimyung Author(s)
Park, Keon Uk
Department
Dept. of Internal Medicine (내과학)
Journal Title
Breast
Issued Date
2022
Volume
65
Keyword
Clinical trialHER2 positiveMetastatic breast cancerTrastuzumab biosimilarctDNA
Abstract
We investigated the efficacy and safety of a trastuzumab biosimilar, Herzuma®, in combination with treatment of physician's choice (TPC) in patients with HER2+ metastatic breast cancer (MBC) who had failed at least two HER2 directed chemotherapies.
Keimyung Author(s)(Kor)
박건욱
Publisher
School of Medicine (의과대학)
Type
Article
ISSN
0960-9776
Source
https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S0960977622001333?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0960977622001333%3Fshowall%3Dtrue&referrer=https:%2F%2Fpubmed.ncbi.nlm.nih.gov%2F
DOI
10.1016/j.breast.2022.08.002
URI
https://kumel.medlib.dsmc.or.kr/handle/2015.oak/44511
Appears in Collections:
1. School of Medicine (의과대학) > Dept. of Internal Medicine (내과학)
공개 및 라이선스
  • 공개 구분공개
파일 목록

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.